Get started
Author

Michael J. Durcan

Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation
2001 · J. Taylor Hays, Richard D. Hurt, et al. · Annals of Internal Medicine · 344
Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics
2010 · David M. Cole, Christian F. Beckmann, et al. · NeuroImage · 184
The effect of bupropion sustained-release on cigarette craving after smoking cessation
2002 · Michael J. Durcan, Greg Deener, et al. · Clinical Therapeutics · 109
Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression
1990 · L.A. Hilakivi-Clarke, K.M. Wozniak, et al. · Physiology & Behavior · 98
Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene
1997 · Brock A. Beamer, Carlo Negri, et al. · Biochemical and Biophysical Research Communications · 86
Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation
2002 · Andrew J. Johnston, John Ascher, et al. · Drugs · 81
Identification of Tryptophan 2,3‐Dioxygenase RNA in Rodent Brain
1993 · Roberta Haber, Daniel Bessette, et al. · Journal of Neurochemistry · 81
Evidence for adenosine A2 receptor involvement in the hypomobility effects of adenosine analogues in mice
1989 · Michael J. Durcan, Philip F. Morgan · European Journal of Pharmacology · 80
Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice
1988 · Michael J. Durcan, Richard G. Lister · Psychopharmacology · 72
Bupropion for pharmacologic relapse prevention to smoking
2002 · Richard D. Hurt, Troy D. Wolter, et al. · Addictive Behaviors · 57
The Effects of Nicotine Replacement on Cognitive Brain Activity During Smoking Withdrawal Studied with Simultaneous fMRI/EEG
2011 · John D Beaver, Christopher J Long, et al. · Neuropsychopharmacology · 56
PDF
Efficacy of a Nicotine (4 mg)-Containing Lozenge on the Cognitive Impairment of Nicotine Withdrawal
2008 · Giuseppe Atzori, Charlotte A. Lemmonds, et al. · Journal of Clinical Psychopharmacology · 49
Interactions of serotonin with ethanol: clinical and animal studies.
1987 · M Linnoila, M Eckardt, et al. · PubMed · 42
α-Adrenoceptor number and function in rat cortex after ethanol and immobilization stress
1983 · Marina Lynch, John Littleton, et al. · Brain Research · 41
Impact of Prior Nicotine Replacement Therapy on Smoking Cessation Efficacy
2002 · Michael J. Durcan, Jonathan D. White, et al. · American Journal of Health Behavior · 36
Differences in the stereotypy response but not the hypomotility response to apomorphine in the roman high and low avoiding strains of rats
1984 · M. J. Durcan, D. W. Fulker, et al. · Psychopharmacology · 36
Behavioral effects of alpha2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice
1989 · Michael J. Durcan, Richard G. Lister, et al. · Psychopharmacology · 35
NECA-induced hypomotility in mice: Evidence for a predominantly central site of action
1989 · Michael J. Durcan, Philip F. Morgan · Pharmacology Biochemistry and Behavior · 35
Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonists
1989 · Richard G. Lister, Michael J. Durcan, et al. · Life Sciences · 34
Does directed exploration influence locomotor activity in a holeboard test?
1989 · Michael J. Durcan, Richard G. Lister · Behavioral and Neural Biology · 34
Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration
1988 · Michael J. Durcan, Richard G. Lister, et al. · Psychopharmacology · 30
Antagonism of the intoxicating effects of ethanol by the potent benzodiazepine receptor ligand Ro 19-4603
1989 · Richard G. Lister, Michael J. Durcan · Brain Research · 29
Effects of caffeine on social behavior, exploration and locomotor activity: Interactions with ethanol
1989 · Leena A. Hilakivi, Michael J. Durcan, et al. · Life Sciences · 28
Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: A randomized, open-label, single-dose, two-way crossover study in adult smokers
2010 · Angela M. DeVeaugh-Geiss, Lilan H. Chen, et al. · Clinical Therapeutics · 26
Is NAN-190 an effective antagonist of the hypothermia and hyperglycemia induced by the 5-HT1A receptor agonist, 8-OH-DPAT?
1991 · Krystyna M. Wozniak, Michael J. Durcan, et al. · European Journal of Pharmacology · 22
Works count: 66
Citation count: 2,077
H-index: 24
I10-index: 43
Year
Topic
Type